SynthesisBMC ophthalmology2026
iStent combined with phacoemulsification versus phacoemulsification alone in open-angle glaucoma: a meta-analysis by medication washout status.
Synthesis in BMC ophthalmology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo assess how preoperative medication washout influences the interpretation of intraocular pressure (IOP) outcomes in randomized controlled trials (RCTs) comparing iStent combined with phacoemulsification versus phacoemulsification alone.
methodsSystematic searches in PubMed, Embase, Web of Science, Cochrane Library, and ClinicalTrials.gov were conducted through December 2025. RCTs comparing combined surgery versus phacoemulsification alone in open-angle glaucoma were included. Random-effects meta-analyses pooled weighted mean differences (WMDs) for IOP and medications, stratified by washout status and follow-up duration.
resultsFive RCTs (915 eyes) were included. In short-term follow-up (≤ 15 months), IOP reduction did not differ significantly between groups. In long-term follow-up (> 15 months), combined surgery showed greater IOP reduction in trials with medication washout (WMD = 1.29 mmHg; 95% CI: 0.61 to 1.97) but not in trials without washout (WMD = 0.69 mmHg; 95% CI: -2.25 to 3.63). Combined surgery consistently reduced medication use (WMD = 0.39) and increased the likelihood of medication-free status (RR = 1.31; 95% CI: 1.15 to 1.51).
conclusionsPreoperative washout status substantially influences IOP outcome quantification. In patients assessed without washout, where baseline IOP is medically controlled, the principal benefit of combined surgery is sustained medication burden reduction rather than additional numerical IOP lowering.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.